Barclays' Matthew Taylor reiterated Telefex Incorporated TFX at Overweight, raising the price target to $183.00. The price objective change came after the analyst met with management last week.
Market News and Data brought to you by Benzinga APIs"The TFX business appears healthy," stated the analyst. Taylor listed five highlights behind the price target increase:
- Utilization has trended positively in the United States
- The company expected to be active on the M&A front
- There are several upside drivers to margins
- GPO wins hit a new record in 1Q
- The company's "Percuvance launch is on track for 3Q in the US"
At the time of writing, Telefex traded at $173.24, up 0.01 percent.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorLong IdeasHealth CarePrice TargetReiterationAnalyst RatingsTechTrading IdeasGeneralBarcalysMatthew Taylor
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in